Preliminary survivorship report on combined intraoperative radiation and hyperthermia treatments for unresectable pancreatic adenocarcinoma
Ashayeri, E.; Bonney, G.; DeWitty, R.L.; Goldson, A.L.; Leffall, L.D.; Thomas, J.N.
Journal of the National Medical Association 85(1): 36-40
1993
ISSN/ISBN: 0027-9684 PMID: 8426382 Document Number: 406553
Five patients with unresectable pancreatic adenocarcinoma were treated with simultaneous intraoperative radiotherapy and intraoperative hyperthermia. Postoperative survivorship averaged 15.8 months, which compares favorably to a previous study in which 19 patients receiving intraoperative radiotherapy without intraoperative hyperthermia survived an average of 6.05 months. Three of the five patients following the experimental protocol of intraoperative radiotherapy and intraoperative hyperthermia with additional external beam radiotherapy are still alive, which may result in average postoperative survivorship exceeding 15.8 months.